Literature DB >> 6734648

Effect of adenosine triphosphate on the accessory pathways.

B Perrot, J P Clozel, G Faivre.   

Abstract

To determine the site of the anterograde and retrograde conduction in the Wolff-Parkinson-White syndrome (WPW), 40 mg of adenosine triphosphate (ATP) was injected during electrophysiological studies in 53 patients with ventricular preexcitation. In 40 cases, the accessory pathway was evident (group 1) and in 13 cases it was concealed (group 2). In 10 cases in group 1, anterograde conduction was abolished with disappearance of the features of preexcitation. In 7 patients of group 1 and in 4 patients of group 2, retrograde conduction in the accessory pathway was prolonged or abolished. These effects were unexpected because ATP is a parasympathomimetic drug. There was a correlation between the Kent effective refractory period (ERP) and the action of ATP. When the drug did not change the anterograde and retrograde conduction in the Kent bundle, the anterograde accessory pathway ERP was always less than 230 ms. When ATP only decreased retrograde conduction in the Kent bundle, anterograde accessory pathway ERP was always more than 280 ms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734648     DOI: 10.1093/oxfordjournals.eurheartj.a061672

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

1.  Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.

Authors:  A C Rankin; K G Oldroyd; E Chong; A P Rae; S M Cobbe
Journal:  Br Heart J       Date:  1989-09

2.  Conduction Properties and Ablation of Adenosine Sensitive Accessory Pathways in Children.

Authors:  Chalese Richardson; Eric S Silver; Leonardo Liberman
Journal:  Pediatr Cardiol       Date:  2021-04-23       Impact factor: 1.655

Review 3.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 4.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.